Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Capital Leases (2024 - 2025)

Historic Capital Leases for Vanda Pharmaceuticals (VNDA) over the last 2 years, with Q3 2025 value amounting to $2.8 million.

  • Vanda Pharmaceuticals' Capital Leases changed N/A to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year change of. This contributed to the annual value of $3.1 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Vanda Pharmaceuticals' Capital Leases stood at $2.8 million.
  • In the past 5 years, Vanda Pharmaceuticals' Capital Leases ranged from a high of $3.1 million in Q4 2024 and a low of $2.8 million during Q3 2025